463 related articles for article (PubMed ID: 9570512)
1. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes.
Krebs FC; Mehrens D; Pomeroy S; Goodenow MM; Wigdahl B
J Biomed Sci; 1998; 5(1):31-44. PubMed ID: 9570512
[TBL] [Abstract][Full Text] [Related]
2. T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-kappaB and NFAT with its enhancer region.
Lemieux AM; Paré ME; Audet B; Legault E; Lefort S; Boucher N; Landry S; van Opijnen T; Berkhout B; Naghavi MH; Tremblay MJ; Barbeau B
J Biol Chem; 2004 Dec; 279(51):52949-60. PubMed ID: 15466412
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.
Verhoef K; Sanders RW; Fontaine V; Kitajima S; Berkhout B
J Virol; 1999 Feb; 73(2):1331-40. PubMed ID: 9882338
[TBL] [Abstract][Full Text] [Related]
5. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
Sawaya BE; Khalili K; Amini S
J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
[TBL] [Abstract][Full Text] [Related]
6. Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage.
Ross HL; Nonnemacher MR; Hogan TH; Quiterio SJ; Henderson A; McAllister JJ; Krebs FC; Wigdahl B
J Virol; 2001 Feb; 75(4):1842-56. PubMed ID: 11160683
[TBL] [Abstract][Full Text] [Related]
7. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.
Sparger EE; Shacklett BL; Renshaw-Gegg L; Barry PA; Pedersen NC; Elder JH; Luciw PA
Virology; 1992 Mar; 187(1):165-77. PubMed ID: 1310554
[TBL] [Abstract][Full Text] [Related]
8. Interactions of the transcription factor AP-1 with the long terminal repeat of different human immunodeficiency virus type 1 strains in Jurkat, glial, and neuronal cells.
Canonne-Hergaux F; Aunis D; Schaeffer E
J Virol; 1995 Nov; 69(11):6634-42. PubMed ID: 7474072
[TBL] [Abstract][Full Text] [Related]
9. U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ATF proteins.
Rabbi MF; Saifuddin M; Gu DS; Kagnoff MF; Roebuck KA
Virology; 1997 Jun; 233(1):235-45. PubMed ID: 9201233
[TBL] [Abstract][Full Text] [Related]
10. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M
J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829
[TBL] [Abstract][Full Text] [Related]
11. Sp1 and related factors fail to interact with the NF-kappaB-proximal G/C box in the LTR of a replication competent, brain-derived strain of HIV-1 (YU-2).
Millhouse S; Krebs FC; Yao J; McAllister JJ; Conner J; Ross H; Wigdahl B
J Neurovirol; 1998 Jun; 4(3):312-23. PubMed ID: 9639074
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a glial cell-specific DNA-protein complex formed with the human T cell lymphotropic virus type I (HTLV-I) enhancer.
Wessner R; Tillmann-Bogush M; Wigdahl B
J Neurovirol; 1995 Mar; 1(1):62-77. PubMed ID: 9222343
[TBL] [Abstract][Full Text] [Related]
13. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes.
Henderson AJ; Zou X; Calame KL
J Virol; 1995 Sep; 69(9):5337-44. PubMed ID: 7636977
[TBL] [Abstract][Full Text] [Related]
14. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
15. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
[TBL] [Abstract][Full Text] [Related]
16. nef/long terminal repeat quasispecies from HIV type 1-infected Mexican patients with different progression patterns and their pathogenesis in hu-PBL-SCID mice.
Gómez-Román VR; Vázquez JA; del Carmen Basualdo M; Estrada FJ; Ramos-Kuri M; Soler C
AIDS Res Hum Retroviruses; 2000 Mar; 16(5):441-52. PubMed ID: 10772530
[TBL] [Abstract][Full Text] [Related]
17. CREB and COUP-TF mediate transcriptional activation of the human immunodeficiency virus type 1 genome in Jurkat T cells in response to cyclic AMP and dopamine.
Rohr O; Schwartz C; Aunis D; Schaeffer E
J Cell Biochem; 1999 Dec; 75(3):404-13. PubMed ID: 10536364
[TBL] [Abstract][Full Text] [Related]
18. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
[TBL] [Abstract][Full Text] [Related]
19. Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients.
Burdo TH; Gartner S; Mauger D; Wigdahl B
J Neurovirol; 2004; 10 Suppl 1():7-14. PubMed ID: 14982733
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity.
Ross HL; Gartner S; McArthur JC; Corboy JR; McAllister JJ; Millhouse S; Wigdahl B
J Neurovirol; 2001 Jun; 7(3):235-49. PubMed ID: 11517398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
